Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NP27412A30

SFRS9 Antibody (OTI5G7), Alexa Fluor™ 350, Novus Biologicals™
SDP

Catalog No. NP27412A30 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NP27412A30 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NP27412A30 Supplier Novus Biologicals Supplier No. NBP274152AF350
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

SFRS9 Monoclonal specifically detects SFRS9 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry.

Specifications

Antigen SFRS9
Applications Western Blot, Immunohistochemistry
Classification Monoclonal
Clone OTI5G7
Conjugate Alexa Fluor 350
Dilution Western Blot, Immunohistochemistry
Formulation 50 mM sodium borate with 0.05% sodium azide
Gene Alias Pre-mRNA-splicing factor SRp30C, serine/arginine-rich splicing factor 9, SFRS9, Splicing factor, arginine/serine-rich 9SR splicing factor 9, SRp30c
Gene Symbols SRSF9
Host Species Mouse
Immunogen Full length recombinant protein of human SFRS9 (NP_003760) produced in E.coli.
Quantity 0.1 mL
Primary or Secondary Primary
Gene ID (Entrez) 8683
Target Species Human, Mouse, Rat
Content And Storage Store at 4°C in the dark.
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.